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Abstract
The alkylphosphocholine (APC) class of antineoplastic and antiprotozoal drugs, such as edelfosine and miltefosine, are structural mimics of
lyso-phosphatidylcholine (lyso-PC), and are inhibitory to the yeast Saccharomyces cerevisiae at low micromolar concentrations. Cytotoxic
effects related to inhibition of phospholipid synthesis, induction of an unfolded protein response, inhibition of oxidative phosphorylation, and
disruption of lipid rafts have been attributed to members of this drug class, however, the molecular mechanisms of action of these drugs remain incompletely understood. Cytostatic and cytotoxic effects of the APCs exhibit variability with regard to chemical structure, leading to differences in effectiveness against different organisms or cell types. We now report the comprehensive identification of S. cerevisiae titratableessential gene and haploid nonessential gene deletion mutants that are resistant to the APC drug miltefosine (hexadecyl-O-phosphocholine).
Fifty-eight strains out of 5600 tested displayed robust and reproducible resistance to miltefosine. This gene set was heavily enriched in functions associated with vesicular transport steps, especially those involving endocytosis and retrograde transport of endosome derived vesicles
to the Golgi or vacuole, suggesting a role for these trafficking pathways in transport of miltefosine to potential sites of action in the endoplasmic reticulum and mitochondrion. In addition, we identified mutants with defects in phosphatidylinositol-4-phosphate synthesis (TetO::STT4)
and hydrolysis (sac1D), an oxysterol binding protein homolog (osh2D), a number of ER-resident proteins, and multiple components of the
eisosome. These findings suggest that ER-plasma membrane contact sites and retrograde vesicle transport are involved in the interorganelle
transport of lyso-PtdCho and related lyso-phospholipid-like analogs to their intracellular sites of cytotoxic activity.
Keywords: Saccharomyces; lipid; phosphatidylcholine; alkylphosphocholine; miltefosine; antifungal; drug resistance; transport

Introduction
The alkylphosphocholine (APC) class of drugs are structural analogs of lyso-phosphatidylcholine (lyso-PC), and have been extensively investigated as antineoplastic agents (Gajate et al. 2012;
Gajate and Mollinedo 2014). They also act as effective antiprotozoal compounds, with potent activity against Leishmania
spp. and other apicomplexan parasites (Saraiva et al. 2002;
Santa-Rita et al. 2004; Verma et al. 2007; Aichelburg et al. 2008;
Machado et al. 2010). Leishmania donovani has been investigated
with regard to genetic mechanisms leading to drug resistance,
and miltefosine-resistant strains have been identified in which
a P4-ATPase (lipid flippase) at the plasma membrane is defective, and thus the resistant strain fails to import the toxic compound (Pérez-Victoria et al. 2006; Seifert et al. 2007; Weingärtner
et al. 2010). The APC’s are also active against fungal pathogens
such as Candida albicans and Cryptococcus neoformans (Widmer
et al. 2006; Vila et al. 2015), and the yeast Saccharomyces cerevisiae
has served as a model for studies on drug resistance and

elucidation of the molecular mechanism(s) of action of these
drugs (Hanson et al. 2003; Cuesta-Marbán et al. 2013; Czyz et al.
2013). Although the body of work on APC resistance is extensive,
particularly on mechanisms of action of edelfosine and miltefosine (Figure 1A), an understanding of the precise mechanism(s)
of action of the APC’s remains incomplete, and the intracellular
location of targets and mechanisms of action of these drugs appear to vary from compound to compound and between organisms and cell types.
A main mechanism of drug resistance, however, is clearly attributable to the loss of active transport of the APC’s into cells,
which occurs via P4-family ATPase mediated internalization at
the plasma membrane (Hanson et al. 2003; Riekhof and Voelker
2009). In the extensively studied L. donovanii system, disruption
of the miltefosine transporter, LdMT (Pérez-Victoria et al.
2006; Seifert et al. 2007) or its noncatalytic b-subunit, LdRos3
(Pérez-Victoria et al. 2006) leads to drug resistance, similar to loss
of the homologous S. cerevisiae proteins Dnf2p or Lem3p,
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in APC treated cells, a corresponding defect in regulation of intracellular pH, and increased sensitivity to low extracellular pH. The
edelfosine-resistant gene deletion mutant set these studies identified was enriched in genes encoding proteins with roles in endocytosis and endosomal transport, as well as in intracellular pH
regulation.
We now report the comprehensive identification of
miltefosine-resistant S. cerevisiae haploid deletion and titratableessential gene strains. While there is overlap with the edelfosineresistant mutant strains, we identified a substantial number of
new mutant strains as miltefosine-resistant, suggesting that the
mechanism(s) by which these compounds exert their cytotoxic
effects are different, and that the mechanisms of fungal resistance to these drugs is not conserved across this drug class. In addition, we identified an oxysterol-binding protein homolog
(Osh2p) as being necessary for miltefosine sensitivity, and suggest that its presence at membrane contact sites is necessary for
efficient APC dissemination to sites of action within the cell. We
further show that proper Osh2p localization is likely to be dependent on the content and localization of phosphatidylinositol-4phosphate, as judged by mislocalization of Osh2p-GFP in
TetO::STT4 and sac1D strains.
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Figure 1 Overlap between previous and current screens for APC
resistance. (A) Structures of APC compounds are discussed in the text in
comparison with lyso-PC.; (B) Venn diagram illustrating the limited
overlap in gene sets between the current study and previous studies on
edelfosine resistance.; (C) Physical and genetic interaction network of
genes identified as being important for both miltefosine and edelfosine
resistance, with additional network neighbors from the miltefosine-only
screen described in this work.

respectively, which leads to edelfosine and miltefosine resistance
in yeast (Hanson et al. 2003). A whole-genome nonessential gene
knockout screen for edelfosine resistant and hypersensitive
mutants of S. cerevisiae was reported in a pair of studies (CuestaMarbán et al. 2013; Czyz et al. 2013). This work showed that edelfosine and miltefosine treatment causes loss of the proton efflux
pump Pma1p from detergent-resistant subdomains of the plasma
membrane. This leads to an apparent mislocalization of Pma1p

All media components were from Fisher Scientific or SigmaAldrich. Routine growth and screening was conducted on YPD
(1% w/v yeast extract, 2% w/v peptone, 2% w/v glucose) or
YPGro (2% v/v glycerol instead of glucose) solidified with 1.5%
w/v agar. Miltefosine was prepared as a 10 mg/ml stock solution
in water, filter sterilized, and stored in frozen aliquots until just
prior to use. Doxycycline was prepared as a 10 mM stock solution in ethanol and added to media (10 mM final concentration)
as needed.
The MATa deletion collection, constructed in parental strain
BY4742 (Baker-Brachmann et al. 1998), and the tetracyclinerepressible essential gene collection, constructed in strain R1158
(Mnaimneh et al. 2004), were purchased from Invitrogen.
Additional osh1D, osh2D, osh3D, and osh1D osh2D osh3D strains in
the SEY6210 background were provided by Tim Levine (University
College London.) Initial screens were conducted by thawing 96well glycerol stock plates, mixing with a stainless steel 96-pin
tool (Dan-Kar model MC-96; Fisher Scientific), and dilution into
150 ml of sterile YPD medium in a 96-well plate. Approximately
3 ml of culture is transferred by each pin under these conditions,
giving a 50 fold dilution in the recipient plate. The diluted cultures were then pinned to solid YPD medium with or without
4 mg/ml (9.8 mM) miltefosine (Avanti Polar Lipids, Alabaster, AL,
USA), incubated at 30  C for up to 7 days, and visually monitored
daily for growth of miltefosine-resistant patches. Cultures from
the essential doxycycline-repressible (“Tet-off”) promoter collection (Mnaimneh et al. 2004) were screened similarly, except that
an additional series of plates were used for the screen, which included 10 mg/ml doxycycline to affect repression of the essential
library gene, as previously described (Wishart et al. 2005).
Miltefosine-resistant strains were identified and subcultured
for further studies. Resistant strains were colony-purified from
patches on the uninhibited miltefosine-free YPD replica plates,
and single colonies were picked and grown to saturation in YPD.
A 10-fold dilution series was prepared in 96-well plates and

J. M. Garcia et al.
pinned to YPD (4 mg/ml miltefosine) or YPGro (1 mg or 4 mg/ml miltefosine) and growth assessed after 48 or 96 hours, respectively.
Strains that showed reproducible miltefosine resistance were
thus identified, and categorized based on degree of sensitivity
with glucose or glycerol as carbon sources.

Bioinformatic analyses
Primary and secondary screening led to the identification of 58
genes which, when deleted or repressed, led to a reproducible
miltefosine-resistant growth phenotype. Gene ontology (GO)
analysis was performed with YeastMine tools available at the
Saccharomyces Genome Database website (www.yeastgenome.
org), and gene set analysis was conducted with YeastNet version
3.0 at www.inetbio.org/yeastnet (Kim et al. 2014).

Microscopy
Strain BY4742 and the isogenic sac1D::KanMX deletion strain were
transformed to uracil prototrohy with plasmid pTS312, a URA3
CEN plasmid expressing a C-terminal GFP fusion of Osh2p, which
was a gift of Christopher Beh (Simon Fraser University.) Cultures
were grown overnight in SC -Ura and imaged on an Evos FL
inverted microscope with GFP fluorescence cube.

Results and discussion
Screening for miltefosine resistant strains
identifies a network of 58 highly connected genes
enriched in membrane and trafficking functions
Table 1 provides a list of the genes that were identified as showing reproducible resistance to 4 mg/ml miltefosine on YPD, and
that rescreened as positive after colony purification of original
stocks and assessment with a fivefold serial dilution spot-test.
Relevant molecular structures are shown in Figure 1A. Figure 2
shows a typical re-screening result for a subset of 6 mutants
from the haploid MATa BY4742 based mutant collection. These
initial results demonstrated that the miltefosine-resistance phenotype is tractable in the context of a genome-wide deletion
screen conducted on solid medium. Figure 5 shows a result
typical of the essential-gene Tet-off screening phenotype
(TetO::STT4), in which we selected strains that showed robust
growth in the presence of miltefosine when doxycycline was present (gene repressed), and weak or absent growth in its absence
(gene expressed normally).
When screening mutant libraries for strains with alterations
in a phenotype of interest, it is useful to assess whether the
screen has identified mutants in a subset of genes with related
functions, or whether the screen has identified a set of diverse
genes with little in common with regard to function or localization. We approached this question by assessing the connectivity
of the identified gene set with regard to systems-based epistasis
screens, protein–protein interaction studies, and other measures,
such as shared protein domain architectures and co-citation indices. We also analyzed the enrichment of GO terms associated
with the gene set. The method of assessment of connectivity
makes use of receiver operating characteristic (ROC) curve analysis (McGary et al. 2007), in which the area under the ROC curve is
assessed in relation to that expected for a randomly chosen subset of genes. The results of ROC analysis for our set of 58 genes
are given in Figure 3. This approach makes use of the YeastNet
v3 database (Kim et al. 2014) to assess whether a set of genes are
more connected to each other than they are to a random subset
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of the genome. This approach led us to discover that miltefosine
resistance is a powerful selection for mutants in a subset of genes
that are highly connected via genetic interactions, protein: protein interactions, and co-citation indices with one another, with a
P-value of 8.3  10 11. This means that that the chances of identifying a random set of genes with this level of connectivity are on
the order of 1 in 10 10. As a control, we selected two random
pools of 58 genes each and analyzed their connectivity by ROC
analysis for the miltefosine-resistance gene set. As expected,
these subsets of genes displayed no significant numbers of connections beyond that which would be expected from random
chance.
A second method of gene set analysis was performed by
assessing the enrichment of GO terms as a measure of relatedness, and allowed us to identify molecular components and processes that are significantly over-represented in the miltefosineresistant mutant collection. Table 2 provides a list of GO terms
that are over-represented in the miltefosine-resistant gene set.
As might be expected for a set of mutants with resistance to a
membrane-perturbing agent, GO components and processes associated with membrane assembly, protein trafficking, and transport through the endomembrane system are highly enriched in
this analysis.

The miltefosine resistant gene deletion set shows
little overlap with a previously described
edelfosine resistance screen
As noted in Figure 1, approximately 264 deletion mutant strains
were previously identified as showing some degree of edelfosine
resistance (Cuesta-Marbán et al. 2013; Czyz et al. 2013). Our current study identified 58 mutants showing resistance to miltefosine, and of those, only 10 mutants were shared between the
edelfosine and miltefosine resistance sets, although this may be
a slight underestimate given that the edelfosine resistance screen
did not encompass the essential gene titratable-promoter collection. Figure 1C shows a composite genetic and physical interaction map of edelfosine-miltefosine resistant shared genes and
their directly interacting partners in the miltefosine resistance
set, and identifies the t-SNARE TLG2 as a key hub in the interaction diagram for the shared edelfosine-miltefosine resistant gene
set.
A tlg2D strain was identified along with dnf2D, lem3D, and
other components of endosome-plasma membrane recycling in
a screen for strains resistant to the lantibiotic peptide Ro 090198 (Takagi et al. 2012). This work also showed that an EGFPtagged Dnf2p reporter was mislocalized in the tlg2D background, suggesting that the Ro-0198 sensitive phenotype of
tlg2D is due to mislocalization of Dnf2p from the plasma membrane to endosomes. Disruption or mislocalization of this lipid
flippase would thus result in the accumulation of phosphatidylethanolamine on the outer leaflet of the plasma membrane,
which is the ligand for this cytolytic peptide. Taken together
with our results, this suggests that localization and proper function of the Dnf2p-Lem3p complex is dependent on Tlg2p and a
small cadre of proteins to which it is functionally linked, and
that the genes in the intersection of the Venn diagram of Figure
1B and in the interaction diagram of Figure 1C encompass the
core components necessary for flippase function, activity, and
localization at the plasma membrane. We thus propose that
while the core components of lysophospholipid uptake (the flippase core components and factors regulating its proper
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Table 1 List of genes identified in the miltefosine-resistance screen
Gene ID

Name

YAL009W
YAL039C
YBR097W
YBR184W
YCR009C
YCR067C
YDL019C
YDR027C
YDR028C
YDR093W
YDR095C
YDR097C
YDR126W
YDR323C
YDR472W
YER031C
YFL047W
YGL012W
YGL054C
YGL095C
YGL106W
YGL158W
YGR086C
YGR141W
YHL028W
YHL031C
YHR012W
YHR108W
YJL154C
YKL212W
YKR001C
YKR019C
YKR020W
YKR068C
YLR039C
YLR082C
YLR093C
YLR305C
YLR360W
YML052W
YML082W
YMR032W
YNL051W
YNL058C
YNL082W
YNL227C
YNL272C
YNL323W
YNR047W
YNR049C
YOL018C
YOL107W
YOR311C
YPL001W
YPL028W
YPR089W
YPR117W
YPR151C

Previous ID

SPO7
CYC3
VPS15

Yes
No
No
No
No
No
No
No
No
Yes
No
No
Yes
No
No
No
No
No
No
No
No
No
No
No
No
No
Yes
No
Yes
No
Yes
No
No
No
No
No
No
No
No
No
Yes
No
No
No
Yes
No
No
Yes
No
No
Yes
No
No
No
No
No
No
No

RVS161
SED4
OSH2
VPS54
REG1
DNF2
MSH6
SWF1
PEP7
TRS31
YPT31
RGD2
ERG4
ERV14
VPS45
MLC1
RCK1
PIL1
VPS62
WSC4
GOS1
VPS29
GGA2
VPS35
SAC1
VPS1
IRS4
VPS51
BET3
RIC1
SRL2
NYV1
STT4
VPS38
SUR7
HOF1
COG5
PMS1
JJJ1
SEC2
LEM3
FPK1
MSO1
TLG2
DGK1
HAT1
ERG10

SUE1

Description

Subunit of Nem1p-Spo7p phosphatase holoenzyme
Cytochrome c heme lyase
Protein kinase involved in vacuolar protein sorting
Putative protein of unknown function
Amphiphysin-like lipid raft protein
ER-protein that stimulates Sar1p GTPase activity
Oxysterol-binding protein homolog family member
Golgi-associated retrograde protein complex
Subunit of type 1 protein phosphatase Glc7p
Aminophospholipid translocase (flippase)
Dubious ORF overlapping DNF2
Required for mismatch repair in mitosis and meiosis
Palmitoyltransferase of SNARE proteins
Vesicle-mediated vacuolar protein sorting
Transport protein particle (TRAPP) I-III
Rab family GTPase
GTPase-activating protein for Cdc42p and Rho5p
C-24(28) sterol reductase
COPII-coated vesicle protein
Protein of the Sec1p/Munc-18 family
Essential light chain for Myo1p
Protein kinase involved in oxidative stress response
Eisosome core component
Vacuolar protein sorting (VPS) protein
Endoplasmic reticulum (ER) membrane protein
v-SNARE protein involved in Golgi transport
Subunit of retromer complex
Regulates Arf1p, Arf2p to facilitate Golgi trafficking
Endosomal subunit of retromer complex
PtdIns-4-phosphate phosphatase
Dynamin-like GTPase required for vacuolar sorting
EH domain-containing protein
Golgi-associated retrograde protein complex
Transport protein particle (TRAPP) complexes I-III
Retrograde transport to the cis-Golgi network
Protein of unknown function
v-SNARE component of vacuolar membrane
Phosphatidylinositol-4-kinase
Vps34p phosphatidylinositol-3-kinase complex
Plasma membrane component of eisosomes
Protein of unknown function
Regulates actin cytoskeleton organization
Conserved oligomeric Golgi complex subunit
Putative protein of unknown function
ATP-binding protein required for mismatch repair
Stimulates the ATPase activity of Ssa1p
Guanyl-exchange factor for small G-protein Sec4p
Beta-subunit of Lem3p flippase
Ser/Thr protein kinase activating Dnf2p
Lipid-interacting protein in SNARE assembly
Syntaxin-like t-SNARE
Putative protein of unknown function
Diacylglycerol kinase
Hat1p-Hat2p histone acetyltransferase complex
Acetyl-CoA C-acetyltransferase
Protein of unknown function
Putative protein of unknown function
Degradation of unstable forms of cytochrome c

Genes are listed in order of chromosomal position as noted from the standard SGD identifier, with gene name (if available), assessment of whether the mutant had
previously been identified as resistant to edelfosine or miltefosine, and a description of the gene product.
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and
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are

broadly

conserved

as

determinants of APC sensitivity, individual members of this
drug class exert their cytotoxic effects by interacting with
multiple and variable intracellular targets after their import
via the flippase.

Disruption of phosphatidylinositol-4-phosphate
homeostasis and the oxysterol-binding protein
homolog Osh2p alters miltefosine sensitivity
The proteins disrupted in a subset of functionally related
miltefosine-resistant mutants (osh2D, sac1D, and TetO::STT4) are
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4 μg/ml Mil

WT
dnf2Δ
Figure 4 Oxysterol binding protein homologs are necessary for wild-type
miltefosine sensitivity. An osh2D strain was identified in the primary
screen conducted in the BY4742 background. To confirm the role of
Osh2p and its orthologs Osh1p and Osh3p and determine whether there
were background-specific differences in sensitivity, we assessed the
growth of strain SEY6210 and isogenic osh1D, osh2D, osh2D, and the triple
mutant. Overnight cultures were subjected to fivefold serial dilution and
pinned to solid media as described in the text.

lem3Δ
fpk1Δ
vps38Δ
cog5Δ
rvs161Δ
Figure 2 Miltefosine-resistance phenotypes. Primary screening led to the
identification of strains with a range of resistance phenotypes. Strains
were grown overnight in YPD and a fivefold serial dilution series was
prepared and pinned to solid YPD agar with (4 mg/ml Mil) or without
(control) miltefosine. Plates were photographed after 3 days. The densest
spots correspond to the 1:25 dilution, and the lightest corresponds to
1:3125 dilution. A range of phenotypes from weakly (fpk1D) to modestly
(cog5D) to strongly (dnf2D and vps38D) resistant are noted.

True positive rate

1.0

0.5

Predicted random
Ctrl Random 1
Ctrl Random 2
Mil-Res gene set

Summary

0
0

0.5
False positive rate

Pleckstrin-homology (PH) domain that interacts with PtdIns-4-P
(Roy and Levine 2004), and a “two phenylalanines in an acidic
tract” (FFAT) motif which interacts with the ER resident proteins
Scs2p and Scs22p (Loewen et al. 2003; Kaiser et al. 2005; Loewen
and Levine 2005).
The phosphatidylinositol (PtdIns) 4-kinase Stt4p (Yoshida et al.
1994; Cutler et al. 1997) generates PtdIns-4-P at the plasma membrane (Foti et al. 2001; Baird et al. 2008), and is involved in actin
polymerization and endocytosis, as well as in transport of PtdSer
from the ER to the site of Psd2p (Trotter et al. 1998). The pool of
PtdIns-4-P generated by Stt4p is degraded by the phosphoinositide phosphatase Sac1p (Foti et al. 2001), which has additional
functions in lipid trafficking and metabolism (Guo et al. 1999;
Rivas et al. 1999; Hughes et al. 2000; Tahirovic et al. 2005; Riekhof
et al. 2014; Tani and Kuge 2014). The strains sac1D, osh2D, and
TetO::STT4 were all identified as miltefosine resistant (Figures 4
and 5), suggesting that the PtdIns-4-P cycle governed by Stt4p
and Sac1p might be involved in the proper localization of Osh2p,
and that mislocalization of Osh2p might lead to a defect in miltefosine uptake and distribution to intracellular targets. This idea
was tested by expressing a GFP-tagged form of Osh2p in a wildtype and sac1D background. As shown in Figure 6, Osh2p in the
wild type is localized in a punctate pattern at the cell periphery,
while in the sac1D mutant Osh2p is localized to intracellular
structures and absent from the cell periphery.

1.0

Figure 3 Receiver-operating characteristic curve analysis. The gene set of
reproducibly miltefosine resistant mutants was analyzed with gene-set
enrichment analysis tools from the YeastNet v3 package at https://www.
inetbio.org/yeastnet/as described in the text. Two sets of randomly
selected genes were analyzed for comparison, and the miltefosineresistant gene set was found to identify genes that were significantly
connected to each other via protein: protein interactions, genetic
epistasis, shared domain architectures, and co-citation indices with an
E-value of less than 1  10 10.

involved in the function and localization of the oxysterol binding
protein homolog Osh2p. Osh2p contains an oxysterol-binding
domain at its C-terminus as well as several protein–protein and
protein: lipid interaction motifs at its N-terminus. These interaction motifs include Anykyrin-repeats which are likely to interact
with other, currently unidentified, proteins (Beh et al. 2001), a

Previous studies in S. cerevisiae (Cuesta-Marbán et al. 2013; Czyz
et al. 2013) have identified a subset of genes that, when deleted,
confer resistance to the APC analog edelfosine. While members
of this drug class share superficial similarities to lysophosphatidylcholine in their structures, it has remained an open question
as to the degree of overlap in their mechanisms of action. Our
current work identifies the plasma membrane flippase Dnf2p
and factors required for its correct localization and function as
being shared between edelfosine, miltefosine, and likely other
members of this drug class with regard to the specific and active
transport of the compounds into the cell. However, unlike the
edelfosine studies, we did not identify factors that regulate intracellular pH or alter the function of the plasma membrane proton
pump Pma1p as having a role in altered miltefosine sensitivity.
We did however identify a new subset of genes as determinants
of wild-type miltefosine sensitivity, and chose to assess the roles
of the PtdIns-4-P cycle and Osh2 localization in more detail. One
interpretation of this data is that after the initial “flip” across the
plasma membrane by Dnf2p/Lem3, miltefosine is transported to
one or more sites of cytotoxic activity by nonvesicular transport
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No addition

+Dox

+Mil

+Dox +Mil

WT
lem3Δ
TetO::STT4
sac1Δ
Figure 5 The phosphatidylinositol-4-kinase/phosphatase cycle is a determinant of miltefosine sensitivity. The essential gene STT4, encoding the major
PtdIns-4-kinase isoform in yeast, was identified in the essential-titratable gene collection. Inhibition of STT4 expression by including doxycycline in the
growth media (10 mM) led to mitefosine resistance (4 mg/ml) The PtdIns-4-P phosphatase Sac1p, was also identified, and a sac1D strain was included in
this series, and lem3D was included as a previously characterized miltefosine resistant positive control. Fivefold serial dilutions were prepared and
pinned to solid media as described in the text.

Table 2 Gene-ontology term enrichment
GO identifier

GO: 0005794
GO: 0000139
GO: 0031201
GO: 0005768
GO: 0016020
GO: 0010008
GO: 0000938
GO: 0034272
GO: 0030906
GO: 0030904
GO: 0006810
GO: 0015031
GO: 0016192
GO: 0006897
GO: 0006896
GO: 0006623
GO: 0042147
GO: 0006914
GO: 0032258
GO: 0006906
GO: 0006895
GO: 0006869
GO: 0045053
GO: 0000011
GO: 0006904
GO: 0048017
GO: 0060988

GO component (C) or process (P)

C: Golgi apparatus
C: Golgi membrane
C: SNARE complex
C: endosome
C: membrane
C: endosome membrane
C: GARP complex
C: phosphatidylinositol 3-kinase complex II
C: retromer complex, inner shell
C: retromer complex
P: transport
P: protein transport
P: vesicle-mediated transport
P: endocytosis
P: Golgi to vacuole transport
P: protein targeting to vacuole
P: retrograde transport, endosome to Golgi
P: autophagy
P: CVT pathway
P: vesicle fusion
P: Golgi to endosome transport
P: lipid transport
P: protein retention in Golgi apparatus
P: vacuole inheritance
P: vesicle docking involved in exocytosis
P: inositol lipid-mediated signaling
P: lipid tube assembly

Total for term

Identified

Fold enrichment

214
121
25
114
1718
59
4
4
4
5
793
389
140
88
24
48
19
51
38
20
14
21
11
18
10
5
3

17
10
5
8
31
5
2
2
2
2
22
17
10
8
5
5
5
4
4
4
3
3
3
3
3
2
2

8.2
8.5
20.7
7.2
1.9
8.8
51.6
51.6
51.6
41.3
2.9
4.5
7.4
9.4
21.5
10.8
27.2
8.1
10.9
20.7
22.1
14.8
28.2
17.2
31.0
41.3
68.9

P-value

6.92E-12
1.77E-07
3.26E-06
1.16E-05
5.54E-05
0.0002392
0.0005458
0.0005458
0.0005458
0.0009041
1.74E-06
7.43E-08
6.98E-07
1.64E-06
2.63E-06
8.87E-05
7.46E-07
0.001407
0.0004564
3.41E-05
0.0002905
0.001012
0.0001344
0.0006335
9.84E-05
0.0009041
0.0002746

Genes identified in the mutant screen were analyzed with GO-based gene-set enrichment analysis tools available at www.yeastgenome.org. P-values were
calculated based on the hypergeometric test, and GO terms with P < 0.005 are included in the table.

routes that are dependent on the proper localization of the
oxysterol-binding protein homolog Osh2p. Future work on this
and other clusters of genes identified in this screen will provide
additional insight into the mechanism(s) of action of miltefosine
and other members of the APC drug class.
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in this work are freely available upon request.
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